# A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation

> **NCT02789358** · NA · COMPLETED · sponsor: **Fundación para la Investigación del Hospital Clínico de Valencia** · enrollment: 140 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **OTHER:** Conventional cryotherapy dosage
- **OTHER:** Experimental cryotherapy dosage
- **DEVICE:** Arctic Front Advance ST Cryoenergy Balloon Catheter
- **DRUG:** Adenosine triphosphate
- **DEVICE:** nECG platform Nuubo®

## Key facts

- **NCT ID:** NCT02789358
- **Lead sponsor:** Fundación para la Investigación del Hospital Clínico de Valencia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2019-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789358, "A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02789358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*